COMMUNIQUÉS West-GlobeNewswire

Informations relatives au nombre total de droits de vote et d’actions composant le capital
20/01/2026
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 20 janvier 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
New Research Reveals Key Quality of Life Insights in ADHD Management
20/01/2026
Qbtech research analyzing nearly 1,000 patients found a correlation between objective ADHD performance and meaningful changes in daily functioning and well-being HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Qbtech , a [...]
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab
20/01/2026
BOSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody [...]
Next-Generation Healthcare Provider ONTO Health Names Dr. Roohi Jeelani Founder & CEO, Expands to Chicago and the Midwest
20/01/2026
ONTO Health is advancing a more comprehensive, human-centered approach to healthcare, supporting health and well-being across the lifespan Chicago, Jan. 20, 2026 (GLOBE NEWSWIRE) -- ONTO Health , a next-generation [...]
Vitalic Health, powered by HFMA, launches U.S. Healthcare Vitals Tracker to measure affordability, financial sustainability and health outcomes
20/01/2026
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association’s Vitalic Health today released the U.S. Vitals Tracker, a first-of-its-kind tool that measures the health of U.S. healthcare. [...]
Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
20/01/2026
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced continued operational growth [...]
Orphai Therapeutics’ Phase 2a LAM-001 Study Selected for Oral Presentation at the American Thoracic Society (ATS) 2026 International Conference
20/01/2026
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Orphai Therapeutics Inc. (“Orphai”) , a clinical-stage biopharmaceutical company dedicated to advancing novel therapeutics for patients with diseases of significant [...]
Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
20/01/2026
Company implements next growth stage following successful strategic and operational development Uwe Buecheler, PhD, Vice Chairman of the Supervisory Board, appointed interim CEO LAUPHEIM, Germany and MILFORD, Mass., Jan [...]
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
20/01/2026
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment FDA’s Fast Track designation for ateganosine in NSCLC advances [...]
Comfort Keepers Ireland Highlights Urgent Need for Scaling Safe, Regulated Home Support
20/01/2026
Report Emphasises the Importance of Home Support in Alleviating Hospital Pressures and Supporting Aging Population Dublin, Ireland, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Comfort Keepers Ireland , a leading homecare provider [...]
Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial
20/01/2026
The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment to begin APTN-101, the Company’s Brain Bispecific T cell Engager (BRiTE), yields [...]
First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical Trials
20/01/2026
Peptinovo Biopharma’s Targeted Cancer Drug Platform Moves to Human Trials in Australia ANN ARBOR, Mich., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering [...]
New National Report: Nurse-Led Coordination Strengthens Patient Access, Reduces Delays and Improves Throughput Across U.S. Health Systems
20/01/2026
Survey finds nurse-first models help avoid three-quarters of unnecessary ED visits, are rated highly effective for reducing readmissions, and enhance patient outcomes through streamlined coordination Cincinnati, Jan. 20 [...]
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
20/01/2026
FDA has requested the HOPE-3 clinical study report (CSR) as part of the BLA review process Company expects to submit updates to the BLA in February 2026 to support continued FDA review SAN DIEGO, Jan. 20, 2026 (GLOBE [...]
TOMI Environmental Solutions Secures UK CES contract integrating SteraMist iHP into Total Clean Air's Modular Cleanroom Platform
20/01/2026
FREDERICK, Md., Jan. 20, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced the sale of a Custom [...]
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/01/2026
MIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the [...]
BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular Edema in Mid-2026
20/01/2026
BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated with intravitreal therapies Growing preclinical and clinical evidence [...]
New Imprivata Survey Finds 85% of Healthcare IT Leaders Think Passwordless Authentication is Vital, but Adoption Lags Significantly
20/01/2026
Just 7% of organizations have fully adopted passwordless authentication, citing technical integration challenges and clinical training concerns WALTHAM, Mass., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Imprivata , a leading [...]
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
20/01/2026
Preliminary 2025 thyroid testing revenue grew 21% over prior year Initial 2026 guidance of 16% growth in thyroid testing revenue All preferred stock converted to common stock Debt-free balance sheet and positive Net [...]

Pages